Healthcare101

 The global in vivo toxicology market in terms of revenue was estimated to be worth $5.0 billion in 2020 and is poised to reach $6.6 billion by 2025, growing at a CAGR of 11.5% from 2020 to 2025. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105308811 In Vivo Toxicology Market Dynamics Driver: Exclusive in vivo toxicology tests With the introduction of alternative methods such as in vitro and in silico toxicology testing, several toxicology tests are conducted through laboratory methods. However, certain tests are exclusive to in vivo toxicology testing, such as tests for carcinogenicity, developmental (including teratogenicity in offspring) & reproductive toxicity, muta...

  [167 Pages Report] The   Global in vivo toxicology market   size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Key attributing factors contributing to the growth of global market include development of innovative animal models and expanding competition in the in vivo toxicology testing market space. However, stringent laws and regulations pertaining to use of animal models in research is expected to emerge as a key challenge to this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105308811 Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing demand for personalized medicine Consumables accounted for the largest share in the in vivo toxicology market in 2019. Based on the product, the in vivo toxicology market is categorized...

 According to the new market research report " In Vivo Toxicology Market by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) - Forecast to 2025", is projected to reach USD 6.6 billion by 2025, at a CAGR of 5.5% between 2020 and 2025. Key Players: Charles River Laboratories (US), The Jackson Laboratory (US),Envigo (US), Taconic Biosciences, Inc. (US), and JANVIER LABS (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Bruker Corporation (US), PerkinElmer (US). Other prominent players includeMerck KGaA (Germany), GE Healthcare (US), and Bio-Rad Laboratories (US), genOway (France), Cyagen Biosciences (US), GVK BIO (India), PolyGene (Switzerland), Crown Biosciences (US), TransCurebioServices (France), Ozgene Pty L...